Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Molecular Cancer Therapeutics|October 15, 2008
Role of histone deacetylase inhibitor-induced reactive oxygen species and DNA damage in LAQ-824/fludarabine antileukemic interactionsRoberto R Rosato, Jorge A Almenara, Sonia C Maggio, et al.
International Journal of Oncology|November 18, 2004
The histone deacetylase inhibitor sodium butyrate induces breast cancer cell apoptosis through diverse cytotoxic actions including glutathione depletion and oxidative stressMonette Louis, Roberto R Rosato, Laurent Brault, et al.
Molecular Cancer Therapeutics|November 9, 2005
Potentiation of the lethality of the histone deacetylase inhibitor LAQ824 by the cyclin-dependent kinase inhibitor roscovitine in human leukemia cellsRoberto R Rosato, Jorge A Almenara, Sonia C Maggio, et al.
Antimicrobial Agents and Chemotherapy|January 7, 2026
Beyond mecA: a two-tiered mechanism and regulatory rewiring drive high-level ceftaroline resistance in clinical MRSAMelissa Sassman, Michele Karolak, Margeurite Dallaire, et al.
Hormone Research|May 15, 2002
Inverse correlation between insulin-like growth factor (IGF)-binding protein-5 and IGF-I and II during postnatal development of the anterior pituitary glandSilvia González-Parra, Roberto R Rosato, Julie A Chowen, et al.
Antimicrobial Agents and Chemotherapy|September 19, 2012
β-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivativesShrenik Mehta, Christopher Singh, Konrad B Plata, et al.
Molecular Pharmacology|September 29, 2005
The histone deacetylase inhibitor LAQ824 induces human leukemia cell death through a process involving XIAP down-regulation, oxidative injury, and the acid sphingomyelinase-dependent generation of ceramideRoberto R Rosato, Sonia C Maggio, Jorge A Almenara, et al.
Pathology|February 28, 2022
Rapid detection of the widely circulating B.1.617.2 (Delta) SARS-CoV-2 variantAdriana E Rosato, Engy Msiha, Bruce Weng, et al.
Molecular Cancer Therapeutics|February 20, 2007
Mechanism and functional role of XIAP and Mcl-1 down-regulation in flavopiridol/vorinostat antileukemic interactionsRoberto R Rosato, Jorge A Almenara, Sarah S Kolla, et al.
Antimicrobial Agents and Chemotherapy|October 12, 2011
VraSR two-component regulatory system contributes to mprF-mediated decreased susceptibility to daptomycin in in vivo-selected clinical strains of methicillin-resistant Staphylococcus aureusShrenik Mehta, Arabela X Cuirolo, Konrad B Plata, et al.
Pageof 5